Veritas Pharma Financials
| VRTHF Stock | USD 0 0.00 0.00% |
Veritas |
Veritas Pharma Stock Summary
Veritas Pharma competes with Green Thumb, Earth Science, and Ascend Wellness. Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2220 Horizon Drive |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.veritaspharmainc.com |
| Phone | 416 918 6785 |
| Currency | USD - US Dollar |
Veritas Pharma Key Financial Ratios
There are many critical financial ratios that Veritas Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Veritas Pharma reports annually and quarterly.| Return On Equity | -5.67 | |||
| Return On Asset | -0.21 | |||
| Beta | -0.0588 | |||
| Total Asset | 730 | |||
| Net Asset | 730 |
Veritas Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Veritas Pharma's current stock value. Our valuation model uses many indicators to compare Veritas Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Veritas Pharma competition to find correlations between indicators driving Veritas Pharma's intrinsic value. More Info.Veritas Pharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Veritas Pharma's earnings, one of the primary drivers of an investment's value.Veritas Pharma Systematic Risk
Veritas Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Veritas Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Veritas Pharma correlated with the market. If Beta is less than 0 Veritas Pharma generally moves in the opposite direction as compared to the market. If Veritas Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Veritas Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Veritas Pharma is generally in the same direction as the market. If Beta > 1 Veritas Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Veritas Pink Sheet analysis
When running Veritas Pharma's price analysis, check to measure Veritas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veritas Pharma is operating at the current time. Most of Veritas Pharma's value examination focuses on studying past and present price action to predict the probability of Veritas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veritas Pharma's price. Additionally, you may evaluate how the addition of Veritas Pharma to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |